Patterns of Comorbidity and In-Hospital Mortality in Older Patients With COVID-19 Infection

Mona Mahmoud1,2, Luca Carmisciano3, Luca Tagliafico1,2

  • 1Geriatrics Clinic, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy.

Frontiers in Medicine
|October 4, 2021
PubMed

Insights

Older adults with specific chronic conditions, particularly neurocognitive and metabolic-renal-cancer clusters, face higher COVID-19 mortality. Identifying these comorbidity patterns aids early risk assessment and intervention for frail patients.

Area of Science:

  • Gerontology and Geriatric Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Older adults are disproportionately affected by severe COVID-19 and mortality.
  • Multimorbidity and disability are known risk factors, but specific clinical features require identification for prognosis.

Purpose of the Study:

  • To identify chronic clinical conditions and comorbidity clusters associated with in-hospital mortality in older COVID-19 patients.
  • To aid in accurate prognosis and appropriate care planning for elderly COVID-19 patients.

Main Methods:

  • Retrospective cohort study of 219 COVID-19 patients aged 70 years or older.
  • Data collected included demographics, chronic medical conditions (multimorbidity), and in-hospital mortality.
  • Comorbidity patterns were clustered into 'Metabolic-renal-cancer', 'Neurocognitive', and 'Unspecified' groups.

Main Results:

  • In-hospital mortality risk was higher for males, older patients, and those with dementia or cerebrovascular disease.
  • The 'Neurocognitive' and 'Metabolic-renal-cancer' comorbidity clusters showed significantly higher mortality.
  • These associations were independent of chronological age and sex.

Conclusions:

  • Specific comorbidity patterns, particularly neurocognitive and metabolic-renal-cancer clusters, identify older adults at higher risk of COVID-19 death.
  • These findings, independent of age, can guide early risk assessment in frail COVID-19 patients.
  • Timely interventions based on identified comorbidity clusters may improve prognosis.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
525
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
43
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
696
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.0K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
74